{
    "2018-07-16": [
        [
            {
                "time": "",
                "original_text": "白雲山：兩產品未通過藥品一致性評價不影響銷售",
                "features": {
                    "keywords": [
                        "白雲山",
                        "產品",
                        "藥品一致性評價",
                        "銷售"
                    ],
                    "sentiment_score": -0.2,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "醫藥"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "白雲山：頭孢氨苄膠囊等2藥品未通過藥品一致性評價",
                "features": {
                    "keywords": [
                        "白雲山",
                        "頭孢氨苄膠囊",
                        "藥品一致性評價"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "醫藥"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}